Lv1
48 积分 2025-04-21 加入
HFpEF and MASLD: converging mechanisms and clinical implications
12天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
15天前
已完结
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
5个月前
已完结
Spatial regulation of glucose and lipid metabolism by hepatic insulin signaling
5个月前
已完结
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
5个月前
已完结
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
6个月前
已完结
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
6个月前
已完结
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
6个月前
已完结
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
6个月前
已完结
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study
7个月前
已关闭
皖公网安备34019202002308
